Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -97.07%-35.1M | -43.16%-10.17M | -196.59%-10.78M | -208.51%-11.56M | -154.28%-10.18M | -69.04%-17.81M | -305.26%-7.11M | -9.09%-3.64M | -7.45%-3.75M | -104.02%-4.01M |
| Net income from continuing operations | -4.40%-16.98M | -449.88%-25.94M | -136.59%-10.64M | -140.65%-9.5M | 1,037.44%29.1M | -67.33%-16.27M | -90.44%-4.72M | -46.96%-4.5M | -90.93%-3.95M | -46.66%-3.1M |
| Operating gains losses | -21,752.26%-1.2M | ---789K | -41,000.00%-409K | ---6K | --2K | ---5.5K | ---- | --1K | ---- | ---- |
| Depreciation and amortization | 13,798.80%11.54M | 34,783.33%4.19M | 12,824.00%3.23M | 15,424.00%3.88M | 1,033.33%238K | 33.70%83K | -38.23%12K | 58.23%25K | 78.25%25K | 63.70%21K |
| Remuneration paid in stock | 157.44%4.07M | 464.35%1.79M | 44.85%1.18M | 173.97%600K | 117.62%494K | 8.30%1.58M | -54.07%317K | 127.32%816K | -3.10%219K | 24.15%227K |
| Deferred tax | ---5.9M | ---1.29M | ---2.34M | ---2.27M | ---- | --0 | --0 | --0 | --0 | ---- |
| Other non cashItems | -730.74%-26.62M | 756.91%8.89M | 239.66%736K | 88.81%-60K | -27,208.57%-28.67M | -58.24%-3.2M | -317.72%-1.35M | 36.98%-527K | 6.21%-536K | 64.19%-105K |
| Change In working capital | ---- | ---- | -563.50%-2.54M | -953.14%-4.21M | -949.03%-3.79M | 20.05%-247.16K | -577.32%-1.61M | 188.53%548K | 145.32%493K | -243.81%-361K |
| -Change in receivables | ---- | ---- | -865.68%-11.45M | -32,613.89%-11.78M | -973.90%-3.17M | -697.82%-2.14M | -1,007.38%-621.4K | -249.10%-1.19M | 34.91%-36K | -604.08%-295K |
| -Change in inventory | ---- | ---- | --107K | --185K | ---350K | ---- | ---- | --0 | --0 | --0 |
| -Change in prepaid assets | ---- | ---- | ---370K | 159.43%63K | -307.58%-269K | -2,921.56%-101.62K | 81.45%70.39K | --0 | -160.73%-106K | 61.99%-66K |
| -Change in payables and accrued expense | ---- | ---- | 429.18%9.18M | 1,053.23%7.32M | --0 | 5,376.57%1.99M | -560.41%-1.06M | 384.99%1.73M | 164.02%635K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -97.07%-35.1M | -43.16%-10.17M | -196.59%-10.78M | -208.51%-11.56M | 20.86%-2.63M | -69.04%-17.81M | -305.26%-7.11M | -9.09%-3.64M | -7.45%-3.75M | -69.23%-3.32M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -6,462.37%-12.21M | -36,875.00%-1.48M | -3.57M | 586.21%846K | -99,900.00%-8M | -52.43%-186K | 92.16%-4K | 0 | -3,768.39%-174K | 68.06%-8K |
| Net PPE purchase and sale | -43,222.22%-7.8M | -36,975.00%-1.48M | ---4.24M | -34,566.67%-2.08M | --0 | 77.99%-18K | 62.83%-4K | --0 | -33.39%-6K | 68.06%-8K |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | -2,523.81%-4.41M | --4K | 268,648.39%666K | 1,841.67%2.93M | ---8M | ---168K | --0 | ---248 | ---168K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -6,462.37%-12.21M | -36,875.00%-1.48M | ---3.57M | 586.21%846K | -99,900.00%-8M | -52.43%-186K | 92.16%-4K | --0 | -3,768.39%-174K | 68.06%-8K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 247.66%85.67M | -78.60%4.43M | 1,498.13%50.45M | -165.61%-519K | 285,045.45%31.34M | 60.29%24.64M | 816.27%20.7M | 619.57%3.16M | 599.29%791K | -100.06%-11K |
| Net issuance payments of debt | 50,406.67%22.64M | 3,163.64%337K | 8.33%-11K | 0.00%-11K | 203,036.36%22.32M | 25.19%-45K | 73.19%-11K | -54.52%-12K | -92.34%-11K | -95.35%-11K |
| Net common stock issuance | 179.50%56.83M | -99.99%2K | --47.44M | --0 | --9.39M | 22.13%20.33M | 5,083,350.00%20.33M | --0 | --0 | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 140.69%10.95M | 943.10%6.05M | 28.31%4.07M | -71.82%226K | --612K | 155.02%4.55M | 284.39%580K | 609.74%3.17M | 573.48%802K | --0 |
| Interest paid (cash flow from financing activities) | ---2.45M | ---718K | ---900K | ---615K | ---173K | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | -1,066.16%-2.31M | ---1.24M | ---137K | ---119K | ---812K | 93.40%-198K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 247.66%85.67M | -78.60%4.43M | 1,498.13%50.45M | -165.61%-519K | 285,045.45%31.34M | 60.29%24.64M | 816.27%20.7M | 619.57%3.16M | 599.29%791K | -100.06%-11K |
| Net cash flow | ||||||||||
| Beginning cash position | 61.02%17.54M | 1,501.65%63.12M | 511.41%27.02M | 406.69%38.25M | 61.02%17.54M | 76.35%10.89M | -74.71%3.94M | -76.14%4.42M | -65.53%7.55M | 76.35%10.89M |
| Current changes in cash | 477.34%38.36M | -153.13%-7.22M | 7,652.93%36.1M | -258.85%-11.23M | 720.02%20.72M | 40.93%6.65M | 389.54%13.59M | 83.71%-478K | 7.35%-3.13M | -121.25%-3.34M |
| End cash Position | 218.79%55.9M | 218.79%55.9M | 1,501.65%63.12M | 511.41%27.02M | 406.69%38.25M | 61.02%17.54M | 61.02%17.54M | -74.71%3.94M | -76.14%4.42M | -65.53%7.55M |
| Free cash from | -140.53%-42.9M | -63.80%-11.66M | -313.09%-15.02M | -263.44%-13.64M | 21.05%-2.63M | -67.97%-17.83M | -303.36%-7.12M | -7.75%-3.64M | -7.49%-3.75M | -67.50%-3.33M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.